Gemcitabine: current status of phase I and II t... [J Clin Oncol. 1994] - PubMed

Related citations

Review Development of gemcitabine in non-small cell lung cancer: the Italian contribution. [Ann Oncol. 2006]
Review Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
Metro G, Cappuzzo F, Finocchiaro G, Toschi L, Crinò L. Ann Oncol. 2006 May; 17 Suppl 5:v37-46.
Gemcitabine in the treatment of non-small-cell lung cancer. [Ann Oncol. 1995]
Gemcitabine in the treatment of non-small-cell lung cancer.
Burkes RL, Shepherd FA. Ann Oncol. 1995; 6 Suppl 3:S57-60.
Review Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review. [Semin Oncol. 1997]
Review Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
Hansen HH, Sørensen JB. Semin Oncol. 1997 Apr; 24(2 Suppl 7):S7-38-S7-41.
Review [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer]. [Gan To Kagaku Ryoho. 2000]
Review [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
Yokoyama A. Gan To Kagaku Ryoho. 2000 Jul; 27(8):1294-300.
Review [Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials]. [Anticancer Drugs. 2001]
Review [Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials].
Crino L, Cappuzzo F. Anticancer Drugs. 2001 Jul; 12 Suppl 3:S9-13.

See reviews... See all...

Cited by 6 PubMed Central articles

Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study. [J Occup Med Toxicol. 2008]
Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.
Xanthopoulos A, Bauer TT, Blum TG, Kollmeier J, Schönfeld N, Serke M. J Occup Med Toxicol. 2008 Dec 18; 3:34. Epub 2008 Dec 18.
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin. [Br J Cancer. 2005]
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin.
Li XM, Tanaka K, Sun J, Filipski E, Kayitalire L, Focan C, Lévi F. Br J Cancer. 2005 May 9; 92(9):1684-9.
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. [Br J Cancer. 2004]
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
Hsu C, Shen YC, Yang CH, Yeh KH, Lu YS, Hsu CH, Liu HT, Li CC, Chen JS, Wu CY, et al. Br J Cancer. 2004 May 4; 90(9):1715-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Gemcitabine: current status of phase I and II trials.
Gemcitabine: current status of phase I and II trials.
J Clin Oncol. 1994 Aug ;12(8):1527-31.

PubMed
Some occupational exposures as risk factors for malignant lymphomas.
Some occupational exposures as risk factors for malignant lymphomas.
Cancer. 1993 Sep 1 ;72(5):1773-8.

PubMed
A descriptive analysis of nonfatal occupational injuries to older workers, using...
A descriptive analysis of nonfatal occupational injuries to older workers, using a national probability sample of hospital emergency departments.
J Occup Environ Med. 1997 Sep ;39(9):855-65.

PubMed
High-and low-frequency fatigue revisited.
High-and low-frequency fatigue revisited.
Acta Physiol Scand. 1996 Mar ;156(3):265-70.

PubMed
Prevalence of shoulder and upper-limb disorders among workers in the fish-proces...
Prevalence of shoulder and upper-limb disorders among workers in the fish-processing industry.
Scand J Work Environ Health. 1993 Apr ;19(2):126-31.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Gemcitabine: current status of phase I and II trials.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Libraries

Supplemental Content

Related citations

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information